Stocks and Finance

Sanofi Aventis

Sanofi Aventis 7/28/2011

03:23 : Sanofi-Aventis 2nd quarter earnings drop - PARIS (AP) -- Sanofi saw its earnings slump 41 percent in the second quarter from a year earlier as growing competition from generic alternatives ate into sales of its more expensive drugs and offset gains from the recent acquisition of U.S. biotechnology ...
Source : usnews-com

Sanofi Aventis 5/10/2011

14:40 : Bullish player takes profits, injects fresh optimism in Sanofi-Aventis ... - SNY - Sanofi-Aventis – The French drug manufacturer popped up on our ‘hot by options volume’ market scanner this morning after one strategist extended bullish sentiment on the stock. Shares in Sanofi-Aventis ...
Source : fxstreet-com

Sanofi Aventis 5/4/2011

07:14 : Sanofi-Aventis ([[SNY]] +1.4%) gets upgraded to Buy from Neutral by BofA, - Sanofi-Aventis (SNY +1.4%) gets upgraded to Buy from Neutral by BofA, which believes shares could be pushed higher on the possibility of an upward revision of FY'11 guidance, cost savings and the potential for ...
Source : seekingalpha-com
02:29 : Sanofi-Aventis upgraded to buy at B. of A. Merrill - LONDON (MarketWatch) -- Bank of America Merrill Lynch on Wednesday upgraded pharmaceuticals group Sanofi-Aventis SA to buy from neutral, saying there are two catalysts that could emerge in ...
Source : marketwatch-com

Sanofi Aventis 4/28/2011

01:22 : Sanofi Q1 tarnished by generics, H1N1 absence - PARIS (Reuters) - Sanofi-Aventis posted a drop in first-quarter earnings, knocked by growing generic competition to several of its top drugs as well as a hole in sales from H1N1 or swine flu...
Source : reuters-com

Sanofi Aventis 4/4/2011

07:33 : Sanofi-Aventis (SNY) completes its improved $20.1B offer for Genzyme (GENZ - Sanofi-Aventis (SNY) completes its improved $20.1B offer for Genzyme (GENZ) after 84.6% of the U.S. company's stock was tendered. Sanofi-Aventis will now start merging the U.S. biotech's operations ...
Source : seekingalpha-com
01:33 : Sanofi-Aventis completes offer for Genzyme - MADRID (MarketWatch) -- French drugmaker Sanofi-Aventis SA on Monday said it has completed its $74-a-share offer for Genzyme Corp. . Sanofi-Aventis said it has completed its exchange offer for all ...
Source : marketwatch-com
00:32 : Sanofi-Aventis says completes offer for Genzyme - PARIS (Reuters) - French drugmaker Sanofi-Aventis completed its improved $20.1 billion offer for Genzyme, allowing it to begin merging the U.S. biotech firm into its business and add rare diseases to its growth areas.
Source : reuters-com

Sanofi Aventis 3/22/2011

08:08 : Merck, sanofi-aventis drop animal health JV plans - Merck (NYSE: MRK) and sanofi-aventis (NYSE: SNY) terminated plans to combine their animal health businesses, citing increasing complexity of implementing the proposed transaction.
Source : ibtimes-com
04:26 : Sanofi-Aventis, Merck End Animal Health-Care Plans - French pharmaceutical giant Sanofi-Aventis and U.S.-based Merck said they have ended plans to combine their animal-health businesses owing to the complexity of the transaction and regulations.
Source : wsj-com

Sanofi Aventis 3/17/2011

02:31 : Epistem Announces Collaboration With sanofi-aventis - MANCHESTER, UNITED KINGDOM--(Marketwire - March 17, 2011) - Epistem plc (LSE:EHP), the UK biotechnology and personalised medicine company today announced a collaboration with sanofi-aventis U.S. Inc. relating to the use of Epistem's ...
Source : marketwire-com

Sanofi Aventis 3/8/2011

04:22 : Sanofi-Aventis plans Europe job cuts: report - TEL AVIV (MarketWatch) -- Sanofi-Aventis, the Paris health-care group, plans to cut as many as 700 jobs as it reorganizes its European operations, a union member told the French daily La Tribune. The plan will reduce the parent's ...
Source : marketwatch-com

Sanofi Aventis 3/7/2011

11:36 : Genzyme board recommends Sanofi Aventis offer - SAN FRANCISCO (MarketWatch) -- Genzyme Corp.'s board on Monday unanimously recommended that shareholders accept a $74-a-share offer from Sanofi Aventis SA . The offer also includes one contingent value right for each ...
Source : marketwatch-com

Sanofi Aventis 2/16/2011

16:38 : Sanofi-Aventis to buy Genzyme for $20 billion - Sanofi-Aventis is buying specialty drugmaker Genzyme for $20.1 billion, the latest example of a beleaguered pharmaceutical company snapping up high-priced biotech drugs to offset dwindling sales of older, simpler medications ...
Source : usnews-com
09:54 : Sanofi-Aventis to buy Genzyme for $20.1B cash - French drug maker Sanofi-Aventis has agreed to buy Genzyme in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion, ...
Source : usatoday-com
03:54 : Europe Markets: Sanofi-Aventis, Heineken lead Europe up - European stocks edge higher, as shares of Sanofi-Aventis rally after it confirms it will buy Genzyme Corp. and brewer Heineken advances after reporting strong results.
Source : marketwatch-com
03:32 : European stocks edge up; Sanofi-Aventis rallies - LONDON (MarketWatch) -- European stocks edged higher Wednesday, extending gains from the previous session, with the Stoxx Europe 600 index trading up 0.2% to 289.90. In France, the CAC 40 index rose 0.4% to 4,147.84, as shares of banking ...
Source : marketwatch-com

Sanofi Aventis 2/15/2011

12:53 : Sanofi-Aventis ([[SNY]] +1%) and Genzyme ([[GENZ]] +3.7%) on quick climbs - Sanofi-Aventis (SNY +1%) and Genzyme (GENZ +3.7%) on quick climbs as Reuters announces agreement in principle on an acquisition deal. (earlier) Post your comment!
Source : seekingalpha-com
12:52 : Having pored over Genzyme's (GENZ) books, Sanofi-Aventis (SNY) reportedly - Having pored over Genzyme's (GENZ) books, Sanofi-Aventis (SNY) reportedly reaches an agreement to acquire the company for $74/share in cash and contingent value rights related to Genzyme's experimental multiple sclerosis drug. Now: ...
Source : seekingalpha-com

Sanofi Aventis 2/9/2011

08:10 : Europe Markets: Sanofi-Aventis, Peugeot lead Europe lower - European stock markets turned mostly lower Wednesday as losses for Sanofi-Aventis and Peugeot as well as a weak session for mining stocks weighed on markets.
Source : marketwatch-com
05:49 : Sanofi-Aventis net profit slumps on restructuring - PARIS (AP) -- Sanofi-Aventis said Wednesday that hefty new restructuring costs caused its net profit to slump 64 percent in the fourth quarter, amid continued uncertainty over the fate of its nearly $20 billion bid for U.S. biotechnology ...
Source : usnews-com
05:36 : Sanofi-Aventis sees lower 2011 earnings - French drugs giant Sanofi-Aventis says talks with its takeover target U.S biotech Genzyme are ongoing, further extending months of suspense surrounding the deal as it forecast an earnings decline this year of between ...
Source : marketwatch-com
03:41 : European shares edge down, LSE jumps on deal news - LONDON (MarketWatch) -- European stocks slipped in early trading Wednesday after a weak session for Asian markets, with several companies under pressure after reporting results. Shares in Sanofi-Aventis dropped 1.9% after the group ...
Source : marketwatch-com
actualidad Sanofi Aventis -


Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts